Literature DB >> 8333799

Acute effects of triiodothyronine on arterial smooth muscle cells.

K Ojamaa1, C Balkman, I L Klein.   

Abstract

Thyroid hormone has profound effects on the heart and cardiovascular system. Systemic vascular resistance is uniformly decreased in both naturally occurring and experimental hyperthyroidism, and it is increased in thyroid hormone deficiency. Because vascular smooth muscle cell contraction is a major determinant of systemic vascular resistance, the present studies were designed to address the acute effects of the thyroid hormones, specifically triiodothyronine, on vascular smooth muscle cell contractile activity. Our data indicate that triiodothyronine causes smooth muscle relaxation; this property may account for some of its marked effects on the cardiovascular system. As a novel vasodilatory agent, the potential therapeutic implications for triiodothyronine may be numerous.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8333799     DOI: 10.1016/0003-4975(93)90556-w

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  15 in total

1.  Immunohistochemical identification of cells expressing ATP-gated cation channels (P2X receptors) in the adult rat thyroid.

Authors:  R Glass; G Burnstock
Journal:  J Anat       Date:  2001-05       Impact factor: 2.610

2.  The Controversies of Hyponatraemia in Hypothyroidism: Weighing the evidence.

Authors:  Ahmed S Abuzaid; Nathan Birch
Journal:  Sultan Qaboos Univ Med J       Date:  2015-05-28

3.  Utility and limitations of biochemical parameters in the evaluation of hyponatremia in the elderly.

Authors:  W Musch; G Decaux
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

4.  Prevalence of echocardiographic criteria for the diagnosis of pulmonary hypertension in patients with Graves' disease: before and after antithyroid treatment.

Authors:  J H Suk; K I Cho; S H Lee; H G Lee; S M Kim; T I Kim; M K Kim; Y K Shong
Journal:  J Endocrinol Invest       Date:  2011-03-07       Impact factor: 4.256

Review 5.  Pharmacotherapy for end-stage coronary artery disease.

Authors:  Neel R Sodha; Louis M Chu; Munir Boodhwani; Frank W Sellke
Journal:  Expert Opin Pharmacother       Date:  2010-02       Impact factor: 3.889

6.  Thyroid hormone analog 3,5-diiodothyropropionic acid promotes healthy vasculature in the adult myocardium independent of thyroid effects on cardiac function.

Authors:  Yingheng Liu; Dajun Wang; Rebecca A Redetzke; Benjamin A Sherer; A Martin Gerdes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

7.  Acute changes in clinical parameters and thyroid function peripheral markers following L-T4 withdrawal in patients totally thyroidectomized for thyroid cancer.

Authors:  C Regalbuto; C Alagona; R Maiorana; R Di Paola; M Cianci; G Alagona; S Sapienza; R Vigneri; V Pezzino
Journal:  J Endocrinol Invest       Date:  2006-01       Impact factor: 4.256

8.  New approaches to thyroid hormones and purinergic signaling.

Authors:  Gabriel Fernandes Silveira; Andréia Buffon; Alessandra Nejar Bruno
Journal:  J Thyroid Res       Date:  2013-07-17

9.  The underlying mechanisms: how hypothyroidism affects the formation of common bile duct stones-a review.

Authors:  Johanna Laukkarinen; Juhani Sand; Isto Nordback
Journal:  HPB Surg       Date:  2012-09-19

10.  Isolated pulmonary arterial hypertension-janus' faces of hyperthyroidism.

Authors:  Beodeul Kang; Deok-Kyu Cho; Ki Hyun Byun; Lucy Youngmin Eun; Yun-Hyeong Cho
Journal:  Korean Circ J       Date:  2009-04-28       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.